HCPCS Level II · Temporary national codes (non-Medicare)
S0171Injection, bumetanide, 0.5 mg
Terminated 12/31/2023
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About S0171
S0171 is an HCPCS Level II code in the S series (temporary national codes (non-Medicare)), describing injection, bumetanide, 0.5 mg.
It was added to HCPCS effective 01/01/2002, and its current record took effect 01/01/2024.
It was terminated on 12/31/2023 and can't be billed for later dates of service.
Its Medicare coverage code is "I", meaning it is not payable by Medicare (another code or method is used).
Details
- Short description
- Bumetanide 0.5 mg
- Date added
- 01/01/2002
- Action effective
- 01/01/2024
- Termination date
- 12/31/2023
- BETOS
- Z2
Related S01xx codes
- S0104Zidovudine, oral, 100 mg
- S0106Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets
- S0108Mercaptopurine, oral, 50 mg
- S0109Methadone, oral, 5 mg
- S0117Tretinoin, topical, 5 grams
- S0119Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)
- S0122Injection, menotropins, 75 iu
- S0126Injection, follitropin alfa, 75 iu
- S0128Injection, follitropin beta, 75 iu
- S0132Injection, ganirelix acetate, 250 mcg
- S0136Clozapine, 25 mg
- S0137Didanosine (ddi), 25 mg
Common questions about S0171
Is HCPCS S0171 still valid?
- No. S0171 was terminated on 12/31/2023.
Does Medicare cover S0171?
- Its coverage code is "I": it is not payable by Medicare (another code or method is used). Check the local coverage determination for your region.